Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells

被引：0
|
作者：
Helena Gbelcová
Silvie Rimpelová
Zdeněk Knejzlík
Jana Šáchová
Michal Kolář
Hynek Strnad
Vanda Repiská
Walter Cosimo D’Acunto
Tomáš Ruml
Libor Vítek
机构：
[1] Comenius University,Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine
[2] University of Chemistry and Technology,Department of Biochemistry and Microbiology
[3] Laboratory of Genomics and Bioinformatics,Institute of Medical Biochemistry and Laboratory Diagnostics, and 4th Department of Internal Medicine, 1st Faculty of Medicine
[4] Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic,undefined
[5] Charles University,undefined
来源：
Lipids in Health and Disease | / 16卷
关键词：
Farnesyl pyrophosphate; Gene expression; Geranylgeranyl pyrophosphate; HMG-CoA reductase inhibitors; Isoprenoids; oncogene; Mevalonate; Pancreatic cancer; Prenylation; Statins;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Investigation of protein prenylation in cancer cells using cell-permeable peptides
    Matijass, Martin
    Klussmann, Merlin
    Klimpel, Annika
    Neundorf, Ines
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [22] Combination effects of MEK inhibitors with statins on cancer cells
    Iizuka-Ohashi, M.
    Watanabe, M.
    Taguchi, T.
    Sakai, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 25 - 25
  • [23] Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications
    Gorabi, Armita Mahdavi
    Kiaie, Nasim
    Pirro, Matteo
    Bianconi, Vanessa
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    HEART FAILURE REVIEWS, 2021, 26 (05) : 1259 - 1272
  • [24] Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications
    Armita Mahdavi Gorabi
    Nasim Kiaie
    Matteo Pirro
    Vanessa Bianconi
    Tannaz Jamialahmadi
    Amirhossein Sahebkar
    Heart Failure Reviews, 2021, 26 : 1259 - 1272
  • [25] Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells
    Pasukoniene, Vita
    Mlynska, Agata
    Steponkiene, Simona
    Poderys, Vilius
    Matulionyte, Marija
    Karabanovas, Vitalijus
    Statkute, Urte
    Purviniene, Rasa
    Krasko, Jan Aleksander
    Jagminas, Arunas
    Kurtinaitiene, Marija
    Strioga, Marius
    Rotomskis, Ricardas
    MEDICINA-LITHUANIA, 2014, 50 (04): : 237 - 244
  • [26] The bisphosphonate zoledronic acid effectively targets lung cancer cells by inhibition of protein prenylation
    Xie, Fan
    Li, Pengcheng
    Gong, Jianhua
    Zhang, Jiahong
    Ma, Jingping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 467 (04) : 664 - 669
  • [27] Bisphosphonates prevent adhesion of breast cancer cells to bone in vitro by inhibiting protein prenylation
    Garrioch, S
    Ebetino, FH
    Rogers, MJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1294 - 1294
  • [28] Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis
    Niess, Hanno
    Camaj, Peter
    Renner, Andrea
    Ischenko, Ivan
    Zhao, Yue
    Krebs, Stefan
    Mysliwietz, Josef
    Jaeckel, Carsten
    Nelson, Peter J.
    Blum, Helmut
    Jauch, Karl-Walter
    Ellwart, Joachim W.
    Bruns, Christiane J.
    TARGETED ONCOLOGY, 2015, 10 (02) : 215 - 227
  • [29] Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis
    Hanno Niess
    Peter Camaj
    Andrea Renner
    Ivan Ischenko
    Yue Zhao
    Stefan Krebs
    Josef Mysliwietz
    Carsten Jäckel
    Peter J. Nelson
    Helmut Blum
    Karl-Walter Jauch
    Joachim W. Ellwart
    Christiane J. Bruns
    Targeted Oncology, 2015, 10 : 215 - 227
  • [30] CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
    Hong, Sung Pil
    Wen, Jing
    Bang, Seungmin
    Park, Seungwoo
    Song, Si Young
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) : 2323 - 2331
12345